Consistent efficacy and safety of teriflunomide were demonstrated in a large clinical trial program.
The PREEMPT clinical trial program was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines and was approved by an Independent Ethics Committee.
The ICHD-2 diagnostic criteria for CM and MOH were evolving as the PREEMPT clinical trial program was developed and launched.
The Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical trial program established the safety and efficacy of onabotulinumtoxinA for CM [7 10].
He earned extra credibility with oncologists by hiring renowned Harvard-trained research oncologist Lloyd Everson as president to build a clinical trial program.
Patients from the PREEMPT clinical trial program who received onabotulinumtoxinA and met our definition for headache-day frequency non-response (<50% reduction in headache-day frequency at week 24) demonstrated significantly reduced headache-day severity (compared with those receiving placebo).
Crizotinib has been acknowledged as standard first line option for ALK-rearranged NSCLC, demonstrating a response rate of 60 74% and a median PFS of 7 11 months based on the "PROFILE" clinical trial program (Table 1) [5, 6, 11 18].
Data from the Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical trial program (a 24-week, 2-treatment cycle, double-blind, randomized, placebo-controlled, parallel-group phase, followed by a 32-week, 3-treatment cycle, open-label phase) were pooled for analysis.
CONCLUSION: This is the largest randomized clinical trial program to date in local prostate cancer and is expected to provide critical information on the role of bicalutamide as an addition to standard care for patients with local prostate cancer who have received a therapy of curative intent or are candidates for watchful waiting.
Finally, the report discusses a number of issues that must be taken into account when mixing modes is deemed necessary or unavoidable within or between trials, including considerations of the risk of mixing at different levels within a clinical trial program and mixing between different types of platforms.
My mother was lucky enough to be accepted into a clinical trial program at the University of Miami Miller School of Medicine.
